ArticleJournal of translational medicine2016

Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer.

Emma Eriksson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.